Business · 16/10/1995Updated: 10/18/2026 · 1 min read

FDA Approves Generic Phenylbutazone Injection for Horses

Summary

The FDA is updating its animal drug regulations to reflect the approval of a generic phenylbutazone injection, filed by Phoenix Scientific, Inc., which will be used as an anti-inflammatory agent in horses.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 9/17/2026

CMS Approves DNV Healthcare USA Inc. for Continued Hospital Accreditation Program Approval

The Centers for Medicare and Medicaid Services (CMS) has approved DNV Healthcare USA Inc. (DNV) for continued recognition as a national accrediting organization for hospitals participating in Medicare and Medicaid programs.

Read summary →

Business · 9/16/2026

Medicare Program; Public Meeting for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Level II Coding

The Centers for Medicare and Medicaid Services (CMS) will hold its second biannual Healthcare Common Procedure Coding System (HCPCS) Level II public meeting of 2026 to discuss new revisions to the HCPCS Level II code set for non-drug and non-biological items and services.

Read summary →

Business · 9/15/2026

World Trade Center Health Program Denies Stroke Petitions

The World Trade Center Health Program Administrator has denied petitions to add stroke to the list of WTC-related health conditions due to insufficient evidence, and therefore will not request a recommendation from the WTC Health Program Scientific/Technical Advisory Committee or publish a proposed rule.

Read summary →

Business · 9/15/2026

World Trade Center Health Program Petition for Peripheral Artery Disease Found Lacking in Evidence

The World Trade Center Health Program Administrator has denied a petition to add peripheral artery disease to the list of WTC-related health conditions due to insufficient evidence, and therefore will not request a recommendation from the WTC Health Program Scientific/Technical Advisory Committee or publish a proposed rule.

Read summary →

Business · 10/9/2026

Center for Scientific Review Notice of Closed Meetings

The Center for Scientific Review has announced closed meetings for the following review groups: the Neurological Sciences A Study Section and the Neurological Sciences B Study Section.

Read summary →

Business · 10/5/2026

CDC Requests Public Comment on Respiratory Protective Devices Data Collection

The Centers for Disease Control and Prevention (CDC) is seeking public input on a proposed data collection project related to Respiratory Protective Devices, as required by the Paperwork Reduction Act of 1995, to inform the approval certification activities under 42 CFR part 84.

Read summary →